Skip to main content
. 2017 Jun 13;8:369. doi: 10.3389/fphar.2017.00369

Table 5.

Laboratory features at baseline and during the 12-months study period in the ANA-treated patients.

Laboratory Baseline (n = 140) (%) 3 months (n = 118) (%) 6 months (n = 109) (%) 12 months (n = 97) (%)
Ferritin
>200 ng/ml 67.8 21.6 8.4 7.3
>1000 ng/ml 47.1 9.2 2.4 2.9
>3000 ng/ml 28.5 3 1.2 0
>10000 ng/ml 10 0 0 0
Eritrocyte sedimentation rate (ESR) 85 32.1 9.1 8.2
C-reactive protein (CRP) 90 30.5 12.8 8.2
Augmented liver enzymes 32.8 5 6.4 3